Results 41 to 50 of about 30,112 (235)

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors

Cancer Medicine, 2020
Precision medicine based on cancer genomics is being applied in clinical practice. However, patients do not always derive benefits from genomic testing. Here, we performed targeted amplicon exome sequencing‐based panel tests, including 160 cancer‐related
Keiko Saotome, Tatsuyuki Chiyoda, Eriko Aimono, Kohei Nakamura, Shigeki Tanishima, Sachio Nohara, Chihiro Okada, Hideyuki Hayashi, Yuka Kuroda, Hiroyuki Nomura, Nobuyuki Susumu, Takashi Iwata, Wataru Yamagami, Fumio Kataoka, Hiroshi Nishihara, Daisuke Aoki   +15 more
doaj   +1 more source

Pseudomyxoma Peritonei - A Case Report

Journal of Nepal Health Research Council, 2021
A 53-year-old lady presented with post-menopausal bleeding (spotting) for two days and abdominal pain for three months. CT scan revealed bilateral adnexal mass and ascites; and CEA and CA19.9 was raised.
Ruhee Tuladhar, Eliza Shrestha, Rishikesh Narayan Shrestha , Anita Thapa, Ashik Rajak   +4 more
doaj   +1 more source

Incidence of lymph node metastases in clinical early-stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study [PDF]

, 2017
Objective: The use of lymph node sampling during staging procedures in clinical early-stage mucinous ovarian carcinoma (MOC) is an ongoing matter of debate. Furthermore, the incidence of lymph node metastases (LNM) in MOC in relation to tumour grade (G)
Buist, M.R., Coffelt, S.B., Kenter, G.G., Lok, C.A.R., van Baal, J.O.A.M., Van de Vijver, K.K., van der Noort, V., van Driel, W.J.   +7 more
core   +2 more sources

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference [PDF]

, 2017
There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment.
Bookman, M, Iida, Y, Jang, JYA, Kaku, T, Kawabata, A, Kim, BG, Kim, JW, Kiyokawa, T, Kuroda, T, Ledermann, J, Matsumura, N, Mikami, Y, Nagayoshi, Y, Oda, K, Okamoto, A, Pujade-Lauraine, E, Quinn, M, Shimada, M, Yanaihara, N   +18 more
core   +2 more sources

An incidental finding of benign Brenner tumor in mucinous cystadenoma of ovary: a case report [PDF]

Journal of Krishna Institute of Medical Sciences University, 2022
Ovarian tumors are common neoplasia in women. Ovarian carcinoma accounts for the 7 cause of mortality and morbidity in females. Surface epithelial tumors are the most common type of ovarian tumor.
Sneha Samir Babaria, Mishal Bhavin Mody, Sushilkumar Suri, Deepak S. Joshi   +3 more
doaj  

Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis [PDF]

, 2015
BACKGROUND: Peritoneal metastasis (PM) is considered a terminal and incurable disease. In the last 30 years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically changed the therapeutic approach for these patients ...
Accarpio, Fabio, Biacchi, Daniele, Cardi, Maurizio, DI GIORGIO, Angelo, Mingarelli, Valentina, Musio, Daniela, Sammartino, Paolo, Sibio, Simone, Sollazzo, BIANCA MARIA   +8 more
core   +2 more sources

Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer

Journal of Ovarian Research, 2019
Background Ovarian cancer is the most lethal of all gynecologic malignancies. The relationship between sexual steroids receptors and ovarian cancer progression has been largely evaluated. The presence of progesterone receptors has been associated with an
Enrique Pedernera, María J. Gómora, Flavia Morales-Vásquez, Delia Pérez-Montiel, Carmen Mendez   +4 more
doaj   +1 more source

Pancreatic tumors imaging: an update [PDF]

, 2016
Currently, ultrasound (US), computed tomography (CT) and Magnetic Resonance imaging (MRI) represent the mainstay in the evaluation of pancreatic solid and cystic tumors affecting pancreas in 80-85% and 10-15% of the cases respectively. Integration of US,
Baccari, Paolo, Cappabianca, Salvatore, D'Andrea, Alfredo, Falcone, Giuseppe, Gravante, Sabrina, Manganaro, Lucia, Palumbo, Barbara, Reginelli, Alfonso, Scialpi, Michele   +8 more
core   +1 more source

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma [PDF]

Clinical Cancer Research, 2013
Abstract Purpose: To investigate the antitumor effects of targeting Src and tubulin in mucinous ovarian carcinoma. Experimental Design: The in vitro and in vivo effects and molecular mechanisms of KX-01, which inhibits Src pathway and tubulin polymerization, were examined in mucinous ovarian cancer models.
Tao, Liu, Wei, Hu, Heather J, Dalton, Hyun Jin, Choi, Jie, Huang, Yu, Kang, Sunila, Pradeep, Takahito, Miyake, Jian H, Song, Yunfei, Wen, Chunhua, Lu, Chad V, Pecot, Justin, Bottsford-Miller, Behrouz, Zand, Nicholas B, Jennings, Cristina, Ivan, Gary E, Gallick, Keith A, Baggerly, David G, Hangauer, Robert L, Coleman, Michael, Frumovitz, Anil K, Sood   +21 more
openaire   +2 more sources

Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature

Diagnostics, 2021
The term “ovarian carcinoma” encompasses at least five different malignant neoplasms: high-grade serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, mucinous carcinoma, and clear cell carcinoma.
Giacomo Santandrea, Simonetta Piana, Riccardo Valli, Magda Zanelli, Elisa Gasparini, Antonio De Leo, Vincenzo Dario Mandato, Andrea Palicelli   +7 more
doaj   +1 more source